Double-crosslinkable poly(urethane)-based hydrogels relying on supramolecular interactions and light-initiated polymerization: promising tools for advanced applications in drug delivery

Physical and chemical hydrogels are promising platforms for tissue engineering/regenerative medicine (TERM). In particular, physical hydrogels are suitable for use in the design of drug delivery systems owing to their reversibility and responsiveness to applied stimuli and external environment. Alternatively, the use of chemical hydrogels represents a better strategy to produce stable 3D constructs in the TERM field. In this work, these two strategies were combined to develop multi-functional formulations integrating both drug delivery potential and TERM approaches in a single device. Specifically, a novel photo-sensitive poly(ether urethane) (PEU) was developed to form supramolecular networks with α-cyclodextrins (α-CDs). The PEU was successfully synthesized using Poloxamer® 407, 1,6-diisocyanatohexane and 2-hydroxyethyl methacrylate, as assessed by infrared spectroscopy, size exclusion chromatography and proton nuclear magnetic resonance (1H NMR) spectroscopy. Subsequently, PEU thermo-responsiveness was characterized through critical micelle temperature evaluation and dynamic light scattering analyses, which suggested the achievement of a good balance between molecular mass and overall hydrophobicity. Consequently, the formation of supramolecular domains with α-CDs was demonstrated through X-ray diffraction and 1H NMR spectroscopy. Supramolecular hydrogels with remarkably fast gelation kinetics (i.e., few minutes) were designed using a low PEU concentration (≤5% w/v). All formulations were found to be cytocompatible according to the ISO 10993-5 regulation. Notably, the hydrogels were observed to possess mechanical properties and self-healing ability, according to rheological tests, and their fast photo-crosslinking was evidenced (<60 s) by photo-rheology. A high curcumin payload (570 μg mL-1) was encapsulated in the hydrogels, which was released with highly tunable and progressive kinetics in a physiological-simulated environment for up to 5 weeks. Finally, a preliminary evaluation of hydrogel extrudability was performed using an extrusion-based bioprinter, obtaining 3D-printed structures showing good morphological fidelity to the original design. Overall, the developed hydrogel platform showed promising properties for application in the emerging field of regenerative pharmacology as (i) easily injectable drug-loaded formulations suitable for post-application stabilization through light irradiation, and (ii) biomaterial inks for the fabrication of patient-specific drug-loaded patches.